These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 17693058

  • 1. Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.
    Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C.
    Cell Signal; 2007 Nov; 19(11):2237-46. PubMed ID: 17693058
    [Abstract] [Full Text] [Related]

  • 2. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
    Song JH, Tse MC, Bellail A, Phuphanich S, Khuri F, Kneteman NM, Hao C.
    Cancer Res; 2007 Jul 15; 67(14):6946-55. PubMed ID: 17638906
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells.
    Song JH, Song DK, Herlyn M, Petruk KC, Hao C.
    Clin Cancer Res; 2003 Sep 15; 9(11):4255-66. PubMed ID: 14519653
    [Abstract] [Full Text] [Related]

  • 4. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 5. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y, Uemoto S.
    J Surg Res; 2007 Oct 07; 142(2):281-6. PubMed ID: 17640673
    [Abstract] [Full Text] [Related]

  • 6. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation.
    Yang BF, Xiao C, Li H, Yang SJ.
    Clin Exp Pharmacol Physiol; 2007 Dec 07; 34(12):1245-51. PubMed ID: 17973862
    [Abstract] [Full Text] [Related]

  • 7. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway.
    Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1328-36. PubMed ID: 19426671
    [Abstract] [Full Text] [Related]

  • 8. Synergistic effect of celecoxib on TRAIL-induced apoptosis in hepatocellular carcinoma cells.
    Lu G, Liu Y, Ji B, Wei F, Hao C, Wang G.
    Cancer Invest; 2010 Jul 15; 28(6):629-34. PubMed ID: 20394499
    [Abstract] [Full Text] [Related]

  • 9. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.
    Gynecol Oncol; 2004 Jun 15; 93(3):594-604. PubMed ID: 15196850
    [Abstract] [Full Text] [Related]

  • 10. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV, Rokhlin OW, Taghiyev AF, Cohen MB.
    Breast Cancer Res Treat; 2008 Feb 15; 107(3):349-57. PubMed ID: 17453339
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T, Suzuki H, Nagai S, Yamamoto K, Imakiire A, Takada E, Itoh M, Mizuguchi J.
    J Orthop Res; 2003 Sep 15; 21(5):949-57. PubMed ID: 12919886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
    Lee J, Hwangbo C, Lee JJ, Seo J, Lee JH.
    Oncol Rep; 2010 Jan 15; 23(1):229-37. PubMed ID: 19956887
    [Abstract] [Full Text] [Related]

  • 15. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY.
    Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound.
    Cheung HH, Mahoney DJ, Lacasse EC, Korneluk RG.
    Cancer Res; 2009 Oct 01; 69(19):7729-38. PubMed ID: 19773432
    [Abstract] [Full Text] [Related]

  • 18. Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes: role of NF-kappaB inhibition.
    Morales JC, Ruiz-Magaña MJ, Ruiz-Ruiz C.
    Mol Immunol; 2007 Apr 01; 44(10):2587-97. PubMed ID: 17257681
    [Abstract] [Full Text] [Related]

  • 19. Role of caspases in CD95L- and TRAIL-induced non-apoptotic signalling in pancreatic tumour cells.
    Siegmund D, Klose S, Zhou D, Baumann B, Röder C, Kalthoff H, Wajant H, Trauzold A.
    Cell Signal; 2007 Jun 01; 19(6):1172-84. PubMed ID: 17291719
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.